An assembly line for medications
Efavirenz can now be produced more cost efficiently and sustainable utilizing continuous flow chemistry.
25-Feb-2015 -
Researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) and the Freie Universität Berlin have succeeded in developing better methods of producing APIs (active pharmaceutical ingredients). As a result, Efavirenz, one of the preferred agents for treating HIV in combination ...
active pharmaceutical ingredients
flow chemistry
HIV
+1